CLVLY
Clinuvel Pharmaceuticals Limited
Set alert
- YTD
- -20.52%
- 1 year
- -3.44%
- Open
- 6.74
- Prev close
- 6.74
- Mkt cap
- 339.88M
- Vol
- 152
- Avg vol
- 3.00K
- EPS
- 0.465
- P/E
- 14.49
More statistics
- Low
- 6.74
- High
- 6.74
News
2 months ago globenewswire.com
A decade of profitability provides foundation for CLINUVEL's U.S. expansion
CLINUVEL PHARMACEUTICALS LTD announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026 (FY2026).
3 months ago globenewswire.com
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce,…
3 months ago globenewswire.com
CLINUVEL's ADS to commence trading on Nasdaq
MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the…
3 months ago globenewswire.com
SCENESSE® approved for EPP in Canada
Health Canada NOC enables treatment for porphyria, metabolic disorder Health Canada NOC enables treatment for porphyria, metabolic disorder
6 months ago globenewswire.com
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo study EMA emphasised its “totality of evidence” approach central photographic review and validated disease…
6 months ago globenewswire.com
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
MELBOURNE, Australia, April 15, 2026 (GLOBE NEWSWIRE) -- CLINUVEL's innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology (AAD) Annual…
8 months ago seekingalpha.com
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2026 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2026 Earnings Call Transcript
1 year ago seekingalpha.com
Clinuvel Pharmaceuticals Limited (CLVLY) Shareholder/Analyst Call Transcript
Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Shareholder/Analyst Call October 16, 2025 7:00 PM EDT Company Participants Jeffrey Rosenfeld Susan Smith Matthew Pringle Malcolm Bull - Head of…
1 year ago globenewswire.com
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Next generation sustained-release formulations for a variety of peptides Next generation sustained-release formulations for a variety of peptides
1 year ago seekingalpha.com
Clinuvel Pharmaceuticals Limited (CLVLY) Q4 2025 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Q4 2025 Earnings Conference Call August 28, 2025 4:00 AM ET Company Participants Malcolm Bull - Head of Australian Operations & Investor Relations Peter…
1 year ago globenewswire.com
CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist
Executive summary plan to upgrade American Depository Receipt (ADR) program (CLVLY) to a Level II ADR listed on Nasdaq, expected before the end of 2025 CLINUVEL's primary listing on the ASX will…
1 year ago globenewswire.com
CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105
CLINUVEL has met its recruitment target in its phase III trial (CUV105) of SCENESSE® (afamelanotide 16mg) in vitiligo, with more than 200 patients enrolled
1 year ago globenewswire.com
Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025
MELBOURNE, Australia, March 03, 2025 (GLOBE NEWSWIRE) -- World-leading photomedicine company CLINUVEL will make its début at the American Academy of Dermatology (AAD) Annual Meeting from March 7–11,…
1 year ago seekingalpha.com
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2025 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Q2 2025 Results Conference Call February 27, 2025 2:00 AM ET Company Participants Stella Mariss - Monsoon Communications Malcolm Bull - Head of IR Peter…
2 years ago globenewswire.com
CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP
MELBOURNE, Australia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- CLINUVEL has filed a New Drug Submission (NDS) to Health Canada, seeking approval for its novel photoprotective therapy SCENESSE®…
2 years ago globenewswire.com
Afamelanotide in fair-skinned Parkinson's patients
MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson's Disease (PD or…
2 years ago globenewswire.com
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE®…
2 years ago globenewswire.com
Malibu shines a light on CLINUVEL's pioneering work in photomedicine
MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California's most prolific investors and philanthropists at…
2 years ago seekingalpha.com
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2023 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2023 Earnings Call Transcript
4 years ago seekingalpha.com
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2022 Results - Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2022 Results - Earnings Call Transcript
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday